Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Research Article28th Annual New Horizons Symposium: The Scientific Basis for Respiratory Care

Airway Clearance Therapy: Finding the Evidence

Teresa A Volsko
Respiratory Care October 2013, 58 (10) 1669-1678; DOI: https://doi.org/10.4187/respcare.02590
Teresa A Volsko
Department of Respiratory Care, Akron Children's Hospital, Akron, Ohio.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Rubin BK
    . Physiology of airway mucus clearance. Respir Care 2002;47(7):761–768.
    OpenUrlPubMed
  2. 2.↵
    1. Warwick WJ
    . Mechanisms of mucous transport. Eur J Respir Dis Suppl 1983;127:162–167.
    OpenUrlPubMed
  3. 3.↵
    1. Foster WM
    . Mucociliary transport and cough in humans. Pulm Pharmacol Ther 2002;15(3):277–282.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.
    1. Zaugg M,
    2. Lucchinetti E
    . Respiratory function in the elderly. Anesthesiol Clin North America 2000;18(1):47–58.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Hernandez ML,
    2. Harris B,
    3. Lay JC,
    4. Bromberg PA,
    5. Diaz-Sanchez D,
    6. Devlin RB,
    7. et al
    . Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challenge. Inhal Toxicol 2010;22(8):648–656.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Habesoglu M,
    2. Demir K,
    3. Yumusakhuylu AC,
    4. Yilmaz AS,
    5. Oysu C
    . Does passive smoking have an effect on nasal mucociliary clearance? Otolaryngol Head Neck Surg 2012;147(1):152–156.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Chaudri MB,
    2. Liu C,
    3. Hubbard R,
    4. Jefferson D,
    5. Kinnear WJ
    . Relationship between supermaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434–438.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hadjikoutis S,
    2. Wiles CM
    . Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand 2001;103(4):207–213.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Van der Schans CP
    . Bronchial mucus transport. Respir Care 2007;52(9):1150–1158.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    1. Voynow JA,
    2. Rubin BK
    . Mucins, mucus, and sputum. Chest 2009;135(2):505–512.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Rubin BK
    . Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 2009;54(6):726–32.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Lester MK,
    2. Flume PA
    . Airway-clearance therapy guidelines and implementation. Respir Care 2009;54(6):733–750.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Lapin CD
    . Airway physiology, autogenic drainage, and active cycle of breathing. Respir Care 2002;47(7):778–85.
    OpenUrlPubMed
  14. 14.↵
    1. Pryor JA
    . Physiotherapy for airway clearance in adults. Eur Respir J 1999;14(6):1418–1424.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Walsh BK,
    2. Hood K,
    3. Merritt G
    . Pediatric airway maintenance and clearance in the acute care setting: how to stay out of trouble. Respir Care 2011;56(9):1424–1440.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Myers TR
    . Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care 2007;52(10):1308–1326.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Chatburn RL
    . High-frequency assisted airway clearance. Respir Care 2007;52(9):1224–1235.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Gauld LM
    . Airway clearance in neuromuscular weakness. Dev Med Child Neurol 2009;51(5):350–355.
    OpenUrlPubMed
  19. 19.↵
    1. Armengot M,
    2. Milara J,
    3. Mata M,
    4. Carda C,
    5. Cortijo J
    . Cilia motility and structure in primary and secondary ciliary dyskinesia. Am J Rhinol Allergy 2010;24(3):175–180.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Carlén B,
    2. Stenram U
    . Primary ciliary dyskinesia: a review. Ultrastruct Pathol 2005;29(3-4):217–220.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Santamaria F,
    2. Montella S,
    3. Tiddens HA,
    4. Guidi G,
    5. Casotti V,
    6. Maglione M,
    7. de Jong PA
    . Structural and functional lung disease in primary ciliary dyskinesia. Chest 2008;134(2):351–357.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Thomas B,
    2. Rutman A,
    3. Hirst RA,
    4. Haldar P,
    5. Wardlaw AJ,
    6. Bankart J,
    7. et al
    . Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol 2010;126(4):722–729.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Verra F,
    2. Escudier E,
    3. Lebargy F,
    4. Bernaudin JF,
    5. De Crémoux H,
    6. Bignon J
    . Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 1995;151(3 Pt 1):630–634.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Jeffery PK
    . Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150(5 Pt 2):S6–S13.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    1. Boucher RC
    . Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007;261(1):5–16.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Boucher RC
    . Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med 2007;13(6):231–240.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Rubin BK
    . Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 2007;8(1):4–7.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Belessis Y,
    2. Dixon B,
    3. Hawkins G,
    4. Pereira J,
    5. Peat J,
    6. MacDonald R,
    7. et al
    . Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012;185(8):862–873.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Regamey N,
    2. Tsartsali L,
    3. Hilliard TN,
    4. Fuchs O,
    5. Tan HL,
    6. Zhu J,
    7. Qiu YS,
    8. Alton EW,
    9. Jeffery PK,
    10. Bush A,
    11. Davies JC
    . Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012;67(2):164–170.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Rubin BK
    . The role of mucus in cough research. Lung 2010;188(Suppl 1):S69–S72.
    OpenUrlPubMed
  31. 31.↵
    1. Zimmer MB,
    2. Nantwi K,
    3. Goshgarian HG
    . Effect of spinal cord injury on the respiratory system: basic research and current clinical treatment options. J Spinal Cord Med 2007;30(4):319–330.
    OpenUrlPubMedWeb of Science
  32. 32.↵
    1. Brown R,
    2. DiMarco AF,
    3. Hoit JD,
    4. Garshick E
    . Respiratory dysfunction and management in spinal cord injury. Respir Care 2006;51(8):853–868.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Fairclough RJ,
    2. Bareja A,
    3. Davies KE
    . Progress in therapy for Duchenne muscular dystrophy. Exp Physiol 2011;96(11):1101–1113.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Chandrasoma B,
    2. Balfe D,
    3. Naik T,
    4. Elsayegh A,
    5. Lewis M,
    6. Mosenifar Z
    . Pulmonary function in patients with amyotrophic lateral sclerosis at disease onset. Monaldi Arch Chest Dis 2012;77(3-4):129–133.
    OpenUrlPubMed
  35. 35.↵
    1. Beardsmore CS,
    2. Wimpress SP,
    3. Thomson AH,
    4. Patel HR,
    5. Goodenough P,
    6. Simpson H
    . Maximum voluntary cough: an indication of airway function. Bull Eur Physiopathol Respir 1987;23(5):465–472.
    OpenUrlPubMedWeb of Science
  36. 36.↵
    1. Chaudri MB,
    2. Liu C,
    3. Hubbard R,
    4. Jefferson D,
    5. Kinnear WJ
    . Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434–438.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Davis PB
    . Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173(5):475–482.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Sivasothy P,
    2. Brown L,
    3. Smith IE,
    4. Shneerson JM
    . Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 2001;56(6):438–444.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Perrin C,
    2. Unterborn JN,
    3. Ambrosio CD,
    4. Hill NS
    . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29(1):5–27.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Hayes RB
    . Of studies, syntheses, synopses and systems: the “4S” evolution of services for finding the current best evidence. ACP J Club 2001;134(2):A11–A13.
    OpenUrlPubMed
  41. 41.↵
    1. Pattishall EN
    . Negative clinical trials in cystic fibrosis research. Pediatrics 1990;85(3):277–281.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Modi AC,
    2. Cassedy AE,
    3. Quittner AL,
    4. Accurso F,
    5. Sontag M,
    6. Koenig JM,
    7. Ittenbach RF
    . Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol 2010;35(9):1028–1037.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Modi AC,
    2. Lim CS,
    3. Yu N,
    4. Geller D,
    5. Wagner MH,
    6. Quittner AL
    . A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006;5(3):177–185.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Arias Llorente RP,
    2. Bousoño García C,
    3. Díaz Martín JJ
    . Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros 2008;7(5):359–367.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Bernard RS,
    2. Cohen LL
    . Increasing adherence to cystic fibrosis treatment: a systematic review of behavioral techniques. Pediatr Pulmonol 2004;37(1):8–16.
    OpenUrlPubMedWeb of Science
  46. 46.↵
    1. Kettler LJ,
    2. Sawyer SM,
    3. Winefield HR,
    4. Grenville HW
    . Determinants of adherence in adults with cystic fibrosis. Thorax 2002;57(5):459–464.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Grossoehme DH,
    2. Opipari-Arrigan L,
    3. VanDyke R,
    4. Thurmond S,
    5. Seid M
    . Relationship of adherence determinants and parental spirituality in cystic fibrosis. Pediatr Pulmonol 2012;47(6):558–566.
    OpenUrlPubMed
  48. 48.↵
    1. Flores JS,
    2. Teixeira FÂ,
    3. Rovedder PM,
    4. Ziegler B,
    5. Dalcin Pde T
    . Adherence to airway clearance therapies by adult cystic fibrosis patients. Respir Care 2013;58(2):279–285.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Myers LB,
    2. Horn SA
    . Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006;11(6):915–926.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Hess DR
    . The evidence for secretion clearance techniques. Respir Care 2001;46(11):1276–1293.
    OpenUrlPubMed
  51. 51.↵
    1. Cook DJ
    . Moving toward evidence-based practice. Respir Care 2003;48(9):859–868.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. McKoy NA,
    2. Saldanha IJ,
    3. Odelola OA,
    4. Robinson KA
    . Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev 2012;(12):CD007862.
  53. 53.↵
    1. Elkins MR,
    2. Jones A,
    3. van der Schans C
    . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2006;(2):CD003147.
  54. 54.↵
    1. Morrison L,
    2. Agnew J
    . Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2009;(1):CD006842.
  55. 55.↵
    1. Elkins M,
    2. Dentice R
    . Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst Rev 2012;(2):CD008816.
  56. 56.↵
    1. Dentice R,
    2. Elkins M
    . Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev 2011;(5):CD007923.
  57. 57.↵
    1. Main E,
    2. Prasad A,
    3. Schans C
    . Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005;(1):CD002011.
  58. 58.↵
    1. Osadnik CR,
    2. McDonald CF,
    3. Jones AP,
    4. Holland AE
    . Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;(3):CD008328.
  59. 59.↵
    1. Cool FD,
    2. Rosen MJ
    . Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):250S–259S.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Flume PA,
    2. Robinson KA,
    3. O'Sullivan BP,
    4. Finder JD,
    5. Vender RL,
    6. Willey-Courand DB,
    7. et al
    ; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522–537.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    1. Kallam A,
    2. Meyerink K,
    3. Modrykamien AM
    . Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: the effect on resource utilization. Respir Care 2013;58(3):431–437.
    OpenUrlAbstract/FREE Full Text
  62. 62.
    1. Colice GL,
    2. Carnathan B,
    3. Sung J,
    4. Paramore LC
    . A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator. J Asthma 2005;42(1):29–34.
    OpenUrlPubMed
  63. 63.
    1. Drescher GS,
    2. Carnathan BJ,
    3. Imus S,
    4. Colice GL
    . Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Respir Care 2008;53(12):1678–1684.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Kollef MH,
    2. Shapiro SD,
    3. Clinkscale D,
    4. Cracchiolo L,
    5. Clayton D,
    6. Wilner R,
    7. Hossin L
    . The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. Chest 2000;117(2):467–475.
    OpenUrlCrossRefPubMedWeb of Science
  65. 65.↵
    1. Shapiro BA,
    2. Cane RD,
    3. Peterson J,
    4. Weber D
    . Authoritative medical direction can assure cost-beneficial bronchial hygiene therapy. Chest 1988;93(5):1038–1042.
    OpenUrlCrossRefPubMed
  66. 66.
    1. Alexander E,
    2. Weingarten S,
    3. Mohsenifar Z
    . Clinical strategies to reduce utilization of chest physiotherapy without compromising patient care. Chest 1996;110(3):430–432.
    OpenUrlCrossRefPubMedWeb of Science
  67. 67.
    1. Homnock DN
    . Making airway clearance successful. Paediatr Respir Rev 2007;8(1):40–45.
    OpenUrlCrossRefPubMedWeb of Science
  68. 68.↵
    1. White D,
    2. Stiller K,
    3. Haensel N
    . Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens. J Cyst Fibros 2007;6(3):163–170.
    OpenUrlPubMed
  69. 69.↵
    1. Christman SL,
    2. Volsko TA
    . Evaluation of an oxygen protocol in long-term care. Respir Care 2006;51(12):1424–1431.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Respiratory Care: 58 (10)
Respiratory Care
Vol. 58, Issue 10
1 Oct 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Monthly Podcast

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Airway Clearance Therapy: Finding the Evidence
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Airway Clearance Therapy: Finding the Evidence
Teresa A Volsko
Respiratory Care Oct 2013, 58 (10) 1669-1678; DOI: 10.4187/respcare.02590

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Airway Clearance Therapy: Finding the Evidence
Teresa A Volsko
Respiratory Care Oct 2013, 58 (10) 1669-1678; DOI: 10.4187/respcare.02590
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Airway Clearance Therapy: What Is It and Why Is It Needed?
    • Indications for Airway Clearance
    • Where to Look for Current Evidence
    • Putting Evidence Into Practice
    • Summary
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • airway clearance devices
  • cough
  • mucociliary transport
  • postural drainage
  • active cycle of breathing
  • positive expiratory pressure
  • oscillatory positive expiratory pressure
  • HFCWO
  • secretion clearance

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire